Physician profile
Bruce Williams
NPI 1033215322
$3,159.67
in general payments reported to CMS, 2019-2025
21 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,114 · 2020: $564 · 2021: $362 · 2022: $394 · 2023: $455 · 2024: $13.86 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,399.45 | 2019-2023 | Xarelto |
| Glaxosmithkline, LLC. | $485.77 | 2019-2023 | Trelegy Ellipta, Shingrix |
| Hikma Pharmaceuticals USA | $209.24 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.42 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $154.25 | 2022-2025 | Zoryve |
| Insmed, INC. | $106.47 | 2019 | |
| Abbvie INC. | $93.91 | 2021-2023 | Linzess |
| Tepha INC | $82.10 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $70.93 | 2019-2025 | Farxiga |
| Lilly USA, LLC | $50.98 | 2020-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $48.43 | 2020-2025 | Ozempic, Rybelsus |
| Allergan, INC. | $46.33 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $37.91 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.70 | 2023 | Trulance, Xifaxan |
| Ironwood Pharmaceuticals, INC | $29.00 | 2023-2024 | Linzess |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $28.58 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $25.78 | 2021 | |
| Pfizer INC. | $25.39 | 2019 | |
| Alkermes, INC. | $24.35 | 2021 | |
| Abbott Laboratories | $24.34 | 2021 | |
| Hologic Sales and Service, LLC | $24.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.